Literature DB >> 30041794

LncRNA MALAT1 sponges miR-203 to promote inflammation in myocardial ischemia-reperfusion injury.

Shuang Wang1, Wenqian Yu2, Jingyi Chen2, Tao Yao2, Fan Deng3.   

Abstract

Entities:  

Keywords:  Inflamation; MALAT1; MiR-203; Myocardial ischemia-reperfusion injury

Mesh：

Substances：

Year:  2018        PMID： 30041794     DOI： 10.1016/j.ijcard.2018.03.085

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  19 in total

Review 1.  Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Authors:  Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

2.  Downregulated miR-203 attenuates IL-β, IL-6, and TNF-α activation in TRAF6-treated human renal mesangial and tubular epithelial cells.

Authors:  Li Zhang; Xingkun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

Review 3.  Involvement of non‑coding RNAs in the pathogenesis of myocardial ischemia/reperfusion injury (Review).

Authors:  Qi Li; Zhuqing Li; Zhixing Fan; Ying Yang; Chengzhi Lu
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

4.  LncRNA AK020546 protects against cardiac ischemia-reperfusion injury by sponging miR-350-3p.

Authors:  Meiqi Zhang; Kang Cheng; Huan Chen; Jianfeng Tu; Ye Shen; Lingxiao Pang; Weihua Wu; Zhenfei Yu
Journal:  Aging (Albany NY)       Date:  2021-05-13       Impact factor: 5.682

5.  Safflor Yellow B Attenuates Ischemic Brain Injury via Downregulation of Long Noncoding AK046177 and Inhibition of MicroRNA-134 Expression in Rats.

Authors:  Chaoyun Wang; Hongzhi Wan; Qiaoyun Wang; Hongliu Sun; Yeying Sun; Kexin Wang; Chunxiang Zhang
Journal:  Oxid Med Cell Longev       Date:  2020-06-03       Impact factor: 6.543

6.  MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR-203 and promoting the expression of BIRC5.

Authors:  Haimin Zhang; Wei Li; Wenyu Gu; Yang Yan; Xudong Yao; Junhua Zheng
Journal:  Cell Prolif       Date:  2019-06-27       Impact factor: 6.831

Review 7.  A Roadmap for Fixing the Heart: RNA Regulatory Networks in Cardiac Disease.

Authors:  Rong Tang; Tianxin Long; Kathy O Lui; Yili Chen; Zhan-Peng Huang
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-25       Impact factor: 8.886

8.  Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway.

Authors:  Xuan Cheng; Zhiwei Liu; Haifeng Zhang; Yajun Lian
Journal:  Cell Cycle       Date:  2021-07-31       Impact factor: 5.173

Review 9.  Regulation of Long Non-coding RNAs and MicroRNAs in Heart Disease: Insight Into Mechanisms and Therapeutic Approaches.

Authors:  Lucy Collins; Pablo Binder; Hongshan Chen; Xin Wang
Journal:  Front Physiol       Date:  2020-07-10       Impact factor: 4.566

Review 10.  Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma.

Authors:  Carlos DeOcesano-Pereira; Raquel A C Machado; Ana Marisa Chudzinski-Tavassi; Mari Cleide Sogayar
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.